Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Faecal Microbiota Transplantation Reduces Lesion Severity and Medication Use in Canine Atopic Dermatitis: A Randomised, Placebo-Controlled, Double-Blinded Clinical Trial.

Veterinary dermatology·2026
Same author

Using native human sera to assess the suitability of external quality assessment materials based on testosterone, progesterone, and 17β-estradiol measurements.

Frontiers in molecular biosciences·2026
Same author

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.

Inflammatory bowel diseases·2026
Same author

Reference Intervals for Serum Ferritin in Older Adults-Results from the Prospective SENIORLAB Study.

Journal of clinical medicine·2026
Same author

Diagnosis-independent contribution of low-grade inflammation to cortical atrophy across psychiatric disorders.

Brain, behavior, and immunity·2026
Same author

Impact of the manufacturing process on the commutability of erythropoietin control materials for external quality assessment schemes.

Frontiers in molecular biosciences·2026

Related Experiment Video

Updated: Apr 30, 2026

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
07:44

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Published on: August 12, 2021

2.3K

SARS-CoV-2 antibody testing-questions to be asked.

Mustafa K Özçürümez1, Andreas Ambrosch2, Oliver Frey3

  • 1Department of Laboratory Medicine of the Medical Clinic at the University Medical Center Knappschaftskrankenhaus Bochum, Ruhr University, Bochum, Germany.

The Journal of Allergy and Clinical Immunology
|June 2, 2020
PubMed
Summary

Understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests is crucial for managing the coronavirus disease 2019 (COVID-19) pandemic. This review clarifies test interpretation factors like sensitivity, specificity, and isotype value for accurate diagnostics and epidemiology.

Keywords:
Antibody responseCOVID-19diagnostic pathwayexternal quality assuranceimmunityimmunoassayneutralization assayrespiratory tract infectionsserologic testssevere acute respiratory syndrome coronavirus 2

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.9K
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

612

Related Experiment Videos

Last Updated: Apr 30, 2026

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
07:44

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Published on: August 12, 2021

2.3K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.9K
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

612

Area of Science:

  • Clinical chemistry and laboratory medicine
  • Infectious disease diagnostics
  • Immunology

Background:

  • Coronavirus disease 2019 (COVID-19) pandemic presents a significant global health challenge.
  • Laboratory diagnostics and immunity assessment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are vital for pandemic control.
  • There is a growing demand for antibody testing, with numerous tests available or in development.

Purpose of the Study:

  • To address the complexities in interpreting SARS-CoV-2 antibody test results.
  • To provide guidance on the diagnostic and epidemiological use of antibody testing.
  • To consolidate current data on SARS-CoV-2 serological assays.

Main Methods:

  • Review of currently available data sets on SARS-CoV-2 antibody testing.
  • Analysis of factors influencing test interpretation, including sensitivity and specificity.
  • Discussion of antibody isotypes, cross-reactivity, and cross-protectivity.

Main Results:

  • Interpretation of SARS-CoV-2 antibody tests is influenced by multiple variables.
  • Factors such as sensitivity, specificity, cross-reactivity, and isotype diagnostics are critical.
  • The utility of antibody testing varies for identifying acutely ill patients versus epidemiological surveillance.

Conclusions:

  • Accurate interpretation of SARS-CoV-2 antibody tests requires careful consideration of various factors.
  • Standardized approaches are needed for reliable diagnostic and epidemiological applications.
  • Further research and data consolidation are essential in this rapidly evolving field.